Literature DB >> 11874887

Reliability of Helicobacter pylori and CagA serological assays.

James E Everhart1, Deanna Kruszon-Moran, Guillermo Perez-Perez.   

Abstract

Background serological assays for Helicobacter pylori are commonly used without knowledge of reliability. This information is needed to define the ability of serological tests to determine either new cases of infection or loss of infection in longitudinal studies. We evaluated the reproducibility and the interrelationships of serological test results for H. pylori and cytotoxin-associated gene product A (CagA) enzyme-linked immunoassays within a subset of participants in a population-based study. Stored samples from 1,229 participants in the third U.S. National Health and Nutrition Examination Survey were replicate serologically tested for H. pylori and CagA. Overall disagreement was 3.4% between duplicate tests for H. pylori (or 2.3% if equivocal results were disregarded). Six percent of samples positive on the first test had an immune serum ratio at least 30% lower on repeat testing. The odds ratio for H. pylori seropositivity on retesting was 2.8 (95% confidence interval [CI] = 1.8 to 4.5) when CagA serology was positive versus when it was negative. CagA antibody was found among 47.8% of H. pylori-equivocal and 7.0% of H. pylori-negative samples. CagA-positive yet H. pylori-negative samples were more likely to occur among Mexican Americans (odds ratio, 5.2; 95% CI = 2.4 to 11.4) and non-Hispanic blacks (odds ratio, 5.5; 95% CI = 2.3 to 13.0) than among non-Hispanic whites. Relying on repeated H. pylori serological tests over time to determine infection rates may result in misinterpretation due to limits in test reproducibility. CagA testing may have a role in verifying infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874887      PMCID: PMC119961          DOI: 10.1128/cdli.9.2.412-416.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  30 in total

1.  Variability of serologic testing for H. pylori using U.S. and Peruvian antigens.

Authors:  S M De Arruda; D J Passaro; J Parsonnet
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

2.  Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette; H Goossens; C DePrez; J P Butzler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

3.  Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population.

Authors:  H Miwa; S Kikuchi; K Ohtaka; O Kobayashi; A Ogihara; M Hojo; A Nagahara; N Sato
Journal:  Diagn Microbiol Infect Dis       Date:  2000-02       Impact factor: 2.803

4.  Validation of a new immunoblot assay for the diagnosis of Helicobacter pylori in the Asian population.

Authors:  W K Leung; T P Chow; E K Ng; F K Chan; S C Chung; J J Sung
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

5.  Accuracy of four commercially available serologic tests, including two office-based tests and a commercially available 13C urea breath test, for diagnosis of Helicobacter pylori.

Authors:  H Cohen; S Rose; D N Lewin; B Retama; W Naritoku; C Johnson; L Bautista; H Crowe; A Pronovost
Journal:  Helicobacter       Date:  1999-03       Impact factor: 5.753

6.  Helicobacter pylori and dyspepsia: a population-based study of the organism and host.

Authors:  C R Locke; N J Talley; D K Nelson; K Haruma; A L Weaver; A R Zinsmeister; L J Melton
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 7.  Recent developments in the epidemiology of Helicobacter pylori.

Authors:  J E Everhart
Journal:  Gastroenterol Clin North Am       Date:  2000-09       Impact factor: 3.806

8.  Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States.

Authors:  J E Everhart; D Kruszon-Moran; G I Perez-Perez; T S Tralka; G McQuillan
Journal:  J Infect Dis       Date:  2000-04-13       Impact factor: 5.226

9.  Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

Authors:  T U Kosunen; K Seppälä; S Sarna; P Sipponen
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

10.  Epidemiological factors of cancer in California.

Authors:  E M Moran
Journal:  J Environ Pathol Toxicol Oncol       Date:  1992 Sep-Oct       Impact factor: 3.567

View more
  11 in total

1.  The impact of Helicobacter pylori on atopic disorders in childhood.

Authors:  I Lisanne Holster; Anne Marie J Vila; Daan Caudri; Caroline M den Hoed; Guillermo I Perez-Perez; Martin J Blaser; Johan C de Jongste; Ernst J Kuipers
Journal:  Helicobacter       Date:  2012-03-20       Impact factor: 5.753

2.  The best method of detecting prior Helicobacter pylori infection.

Authors:  Chien-Yu Lu; Chao-Hung Kuo; Yi-Ching Lo; Hung-Yi Chuang; Yuan-Chieh Yang; I-Chen Wu; Fang-Jong Yu; Yi-Chen Lee; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

Review 3.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

4.  Helicobacter pylori and gastroesophageal reflux disease: a case-control study.

Authors:  Douglas A Corley; Ai Kubo; T R Levin; Gladys Block; Laurel Habel; Gregory Rumore; Charles Quesenberry; Patricia Buffler; Julie Parsonnet
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

5.  Early-life family structure and microbially induced cancer risk.

Authors:  Martin J Blaser; Abraham Nomura; James Lee; Grant N Stemmerman; Guillermo I Perez-Perez
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

6.  A case of Helicobactor pylori negative low-grade gastric MALT lymphoma in an elderly female, successfully treated with rituximab.

Authors:  Naba Raj Mainali; Madan Raj Aryal; Ravi Shahu Khal; Richard Alweis
Journal:  Am J Case Rep       Date:  2013-11-08

7.  Augmentation of Autoantibodies by Helicobacter pylori in Parkinson's Disease Patients May Be Linked to Greater Severity.

Authors:  Gunasekaran Suwarnalata; Ai Huey Tan; Hidayah Isa; Ranganath Gudimella; Arif Anwar; Mun Fai Loke; Sanjiv Mahadeva; Shen-Yang Lim; Jamuna Vadivelu
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

8.  Helicobacter pylori, Vascular Risk Factors and Cognition in U.S. Older Adults.

Authors:  Víctor M Cárdenas; François Boller; Gustavo C Román
Journal:  Brain Sci       Date:  2019-12-12

9.  Asthma is inversely associated with Helicobacter pylori status in an urban population.

Authors:  Joan Reibman; Michael Marmor; Joshua Filner; Maria-Elena Fernandez-Beros; Linda Rogers; Guillermo I Perez-Perez; Martin J Blaser
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

Review 10.  Helicobacter pylori infection, chronic inflammation, and genomic transformations in gastric MALT lymphoma.

Authors:  Magdalena Witkowska; Piotr Smolewski
Journal:  Mediators Inflamm       Date:  2013-03-28       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.